Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Zoia Fesenko"'
Autor:
Zoia Fesenko, Maria Ptukha, Marcelo M. da Silva, Raquel S. Marques de Carvalho, Vassiliy Tsytsarev, Raul R. Gainetdinov, Jean Faber, Anna B. Volnova
Publikováno v:
Biomedicines, Vol 12, Iss 9, p 2114 (2024)
Background/Objectives: Dopamine dysfunction (DA) is a hallmark of many neurological disorders. In this case, the mechanism of changes in dopamine transmission on behavior remains unclear. This study is a look into the intricate link between disrupted
Externí odkaz:
https://doaj.org/article/97f93109cb8e4a96882d022040ad794b
Publikováno v:
IBRO Neuroscience Reports, Vol 15, Iss , Pp S404- (2023)
Externí odkaz:
https://doaj.org/article/743acee117f343c78391dcab57028bab
Autor:
Artem Savchenko, Giorgia Targa, Zoia Fesenko, Damiana Leo, Raul R. Gainetdinov, Ilya Sukhanov
Publikováno v:
Biomolecules, Vol 13, Iss 5, p 806 (2023)
The key element of dopamine (DA) neurotransmission is undoubtedly DA transporter (DAT), a transmembrane protein responsible for the synaptic reuptake of the mediator. Changes in DAT’s function can be a key mechanism of pathological conditions assoc
Externí odkaz:
https://doaj.org/article/94a1467c365b4a11af622c42960bca3b
Autor:
Anna Volnova, Natalia Kurzina, Anastasia Belskaya, Arina Gromova, Arseniy Pelevin, Maria Ptukha, Zoia Fesenko, Alla Ignashchenkova, Raul R. Gainetdinov
Publikováno v:
Biomedicines, Vol 11, Iss 1, p 222 (2023)
Investigation of the precise mechanisms of attention deficit and hyperactivity disorder (ADHD) and other dopamine-associated conditions is crucial for the development of new treatment approaches. In this study, we assessed the effects of repeated and
Externí odkaz:
https://doaj.org/article/cf2937d3de0348638f997c90825dc07d
Autor:
Ilya Sukhanov, Artem Dorotenko, Zoia Fesenko, Artem Savchenko, Evgeniya V. Efimova, Mikael S. Mor, Irina V. Belozertseva, Tatyana D. Sotnikova, Raul R. Gainetdinov
Publikováno v:
Biomolecules, Vol 13, Iss 1, p 9 (2022)
Parkinson’s disease is the second most common neurodegenerative pathology. Due to the limitations of existing therapeutic approaches, novel anti-parkinsonian medicines with non-dopamine mechanisms of action are clearly needed. One of the promising
Externí odkaz:
https://doaj.org/article/c1b30259947a4a0a93e8ff23764eb869
Autor:
Maria Ptukha, Zoia Fesenko, Anastasia Belskaya, Arina Gromova, Arseniy Pelevin, Natalia Kurzina, Raul R. Gainetdinov, Anna Volnova
Publikováno v:
Biomolecules, Vol 12, Iss 10, p 1484 (2022)
Changes in dopaminergic and noradrenergic transmission are considered to be the underlying cause of attention deficit and hyperactivity disorder (ADHD). Atomoxetine (ATX) is a selective norepinephrine transporter (NET) inhibitor that is currently use
Externí odkaz:
https://doaj.org/article/3fda832f0ffc4dd884f7c04b4e77a70b
Publikováno v:
Neuroscience Letters. 788:136839
Dopamine in the brain is involved in many important functions, including the regulation of wakefulness. There is also some evidence suggesting that the dopamine function is crucial in anesthetic function. The state of anesthesia is characterized by a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::315654e6bb670efd7618437e64b99d47
https://doi.org/10.1016/j.neulet.2022.136839
https://doi.org/10.1016/j.neulet.2022.136839